TSC1 and plasma cell myeloma: Previous reports show that changes in TSC1 or miR-130a expression is associated with the modulation of one or more of the cellular properties like proliferation, apoptosis, colony forming ability and invasion in several cancers such as prostate, multiple myeloma, gastric, SACC, and ovarian cancer20,30,33–35,43,44.